Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
about
The role of singlet oxygen and oxygen concentration in photodynamic inactivation of bacteria.Pulsed diode laser-based singlet oxygen monitor for photodynamic therapy: in vivo studies of tumor-laden rats.Nonesterified cholesterol content of lysosomes modulates susceptibility to oxidant-induced permeabilization.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters.Photodynamic therapy of cancer: an updatePhotobleaching and phototoxicity of KillerRed in tumor spheroids induced by continuous wave and pulsed laser illumination.Study of tissue oxygen supply rate in a macroscopic photodynamic therapy singlet oxygen model.The redox biology network in cancer pathophysiology and therapeuticsNew photosensitizers for photodynamic therapySelf-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic TherapyAscorbate reacts with singlet oxygen to produce hydrogen peroxide.Evaluation of phototoxicity of dendritic porphyrin-based phosphorescent oxygen probes: an in vitro study.Determination of the low concentration correction in the macroscopic singlet oxygen model for PDT.PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy.Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.Explicit macroscopic singlet oxygen modeling for benzoporphyrin derivative monoacid ring A (BPD)-mediated photodynamic therapy.Applications of genetically encoded photosensitizer miniSOG: from correlative light electron microscopy to immunophotosensitizing.Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomesOn the in vivo photochemical rate parameters for PDT reactive oxygen species modeling.Measurement of intracellular oxygen concentration during photodynamic therapy in vitro.Effect of 1O2 quencher depletion on the efficiency of photodynamic therapy.Monitoring photosensitizer uptake using two photon fluorescence lifetime imaging microscopy.Calculation of singlet oxygen dose using explicit and implicit dose metrics during benzoporphyrin derivative monoacid ring A (BPD-MA)-PDT in vitro and correlation with MLL cell survival.TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy.Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions.Generation of hydroxyl radicals and singlet oxygen during oxidation of rhododendrol and rhododendrol-catechol.Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells.Influence of laser wavelength on the damage of comb's vasculature by photodynamic therapy--simulation and validation of mathematical models.A study of concentration changes of Protoporphyrin IX and Coproporphyrin III in mixed samples mimicking conditions inside cancer cells for Photodynamic TherapyIntegration of fluorescence differential path-length spectroscopy to photodynamic therapy of the head and neck tumors is useful in monitoring clinical outcomeInfluence of the Human Skin Tumor Type in Photodynamic Therapy Analysed by a Predictive Model
P2860
Q33281981-6C12FCA9-6AD4-41EE-819D-31CB4FA2FEB2Q33397563-C1E3823C-6036-4D35-8488-8BB49C1FDBDDQ34478831-6384D411-6D20-484B-8341-66889494E152Q34762840-FFEA3299-3ED7-4891-8F01-55A790AB4F38Q35251864-38738321-AC56-4C6D-B5CD-A9A1C3E00145Q35532394-9B837036-8039-4FF1-B635-1C0D979C35FCQ35554620-F460F73D-1534-4F19-96DD-354544D2F53FQ35777005-1AE43ADA-31F0-4302-BE80-BDD0B69A3515Q35849711-C5C5116A-AD5E-44B7-B8DF-DA047EABFC13Q35919257-3B7997B3-8E77-4AA4-B9F4-7204D483D34BQ35961483-971673E1-8E1D-4DD0-BEBB-5BB7B9A54B13Q36286035-7B5A60B0-036F-4C83-977B-382014E68DDBQ36715624-7603EDAB-D9F0-4B83-B2B6-7AF5EC5CCA52Q36760759-3946DA55-88D1-4C0D-9AA5-0B3AEEE0A148Q36983114-223609E3-5484-4998-BBCE-D6621929C300Q37367650-F06DF8F5-783A-4627-B55D-545B9565E89CQ37507149-E2552BC9-B181-4656-BDA1-CFDBF3954FD2Q37676077-D303BFD7-9E25-4669-8F06-CADB20223BF0Q38470678-73DBE6C8-0B42-4370-85E0-3BDD6CD3DA1BQ38737559-2CB66ECE-2EA4-4CD1-A512-6654E3A217D2Q38902450-8AE3BCA0-E85C-4C58-9181-843F36547EC0Q38973386-5FB1EEB0-1782-4F22-B08A-59B9A32A1187Q38976558-C0DA98DD-79BA-48B3-BD19-EAEA71EFFF2CQ39024549-8D0857B6-19CE-4C37-A74D-76BB2277334DQ39051120-D8491388-13B0-4923-950B-D98BBAEE89B9Q39256458-0738DEC1-71DD-4DCD-97F5-EBDB1E732D2EQ39541853-DD9D90F4-D500-4FAE-80B2-CF9B29175CC7Q39675468-DBEB45DC-006B-450C-BD80-9CF7A773EB28Q40333541-B5FC5C13-ABE7-400B-9D44-AE65AF4302F7Q42293490-49C6A382-A436-4BB6-AD5F-54FD2311115FQ44583167-D61744E5-677D-4E02-8F60-002822F77E02Q51602396-E83109E8-D9CB-4B3D-89DC-EDF0C65F8C46Q57166570-331BB7F3-EC07-4D97-B27E-3FD5DEE41C00Q58561519-F20F33B9-38E0-4739-95F2-870F93080576Q58688910-24CC6C88-B467-4D68-81AE-26169CE838B4
P2860
Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Characterization of Photofrin ...... therapy of MLL cells in vitro.
@en
type
label
Characterization of Photofrin ...... therapy of MLL cells in vitro.
@en
prefLabel
Characterization of Photofrin ...... therapy of MLL cells in vitro.
@en
P356
P1476
Characterization of Photofrin ...... therapy of MLL cells in vitro.
@en
P2093
Jonathan S Dysart
Michael S Patterson
P304
P356
10.1088/0031-9155/50/11/011
P577
2005-05-18T00:00:00Z